 Asbestos.com | Earnings Preview: Bristol-Myers to report 4Q CBS News Those include Yervoy for advanced melanoma and transplant rejection drug Nulojix, both approved in the US and Europe, and anti-clotting drug Eliquis. Eliquis was approved in the European Union for preventing clots in patients getting hip or knee ... Bristol-Myers Squibb (BMY) Crosses Pivot Point Support at $32.37 |
